ResTORbio - 48 Year Dividend History | TORC

Historical dividend payout and yield for ResTORbio (TORC) since 1971. The current TTM dividend payout for ResTORbio (TORC) as of July 15, 2019 is $0.00. The current dividend yield for ResTORbio as of July 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.352B $0.000B
resTORbio, Inc. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of therapeutics for the treatment of aging-related diseases. The company's program consists of rapamycin complex 1 pathway to treat aging-related diseases and conditions. Its lead product candidate, RTB101 is an orally administered, small molecule, potent TORC1 inhibitor which is in clinical stage. resTORbio, Inc. is based in BOSTON, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $106.696B 12.06
Gilead Sciences (GILD) United States $84.475B 10.26
CSL Sponsored ADR (CSLLY) Australia $34.985B 0.00
Bio-Techne Corp (TECH) United States $7.927B 54.08